EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access

VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers

Michael Y Shao, Stuart Harlin, Beverly Chan, KathyLee Santangelo, Eri Fukaya, Julianne Stoughton, Raghu Kolluri, VIEW-VLU Investigators

Journal of Vascular Surgery: Venous and Lymphatic Disorders · 2023

DOI: 10.1016/j.jvsv.2023.01.011 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2023. Verfasst von Michael Y Shao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Swedish Hospital, Northshore University HealthSystem, Chicago, IL. Electronic address: MShao@northshore.org. Hauptthemen laut MEDLINE: Ulcer, Varicose Ulcer. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Boston Scientific Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Chronic venous hypertension, triggered by venous reflux and/or obstruction, leads to skin changes and venous leg ulcers (VLUs). Compression therapy is the standard of care, but many wounds remain unhealed. The objectives of this study were to observe the effects of endovenous chemical ablation with commercially available 1% polidocanol injectable microfoam on VLU healing and recurrence rates. METHODS: The VIEW VLU study was a multicenter, open-label, phase IV registry of patients with active VLUs resulting from venous insufficiency of the great saphenous vein and/or anterior accessory saphenous vein systems who underwent ablation with 1% polidocanol microfoam. Primary outcomes included wound healing rate (change in wound perimeter), wound closure at 12 weeks after treatment, and time to wound closure. Secondary outcomes included VLU recurrence, numeric pain score at the ulcer location, EuroQol five-dimension five-level questionnaire quality-of-life index, and the Venous Clinical Severity Score. Patients were followed for 12 months. RESULTS: We enrolled 76 patients (80 ulcers) from 14 sites across the United States and Canada (mean age 63.6 ± 13.7 years, 39.5% female, mean body mass index 36.3). Of the enrollees, 96.3% presented with great saphenous vein incompetence. The mean baseline wound perimeter was 117.2 ± 107.4 mm and 26.3% of wounds (21/80) were circumferential. The mean ulcer age was 34.8 ± 51.8 weeks at first presentation and the mean compression therapy duration was 26.4 ± 35.9 weeks. The median wound perimeter decreased by 16.3% from baseline in the first 2 weeks after the procedure and by 27.0% at 12 weeks. By 12 weeks, 53.8% of wounds (43/80) were healed. The median time to ulcer closure by Kaplan-Meier analysis was 89 days (95% confidence interval, 62.0-117.0). In a Kaplan-Meier analysis of initially healed wounds, 88.9% (95% confidence interval, 76.9-94.8) remained closed at 12 weeks after closure. The mean numeric pain scores (ulcer site) improved by 41.0% and 64.1% at 12 weeks and 12 months after the procedure, respectively. The health-related quality-of-life index (scale of 0-1) improved from 0.65 ± 0.27 at baseline to 0.72 ± 0.28 at 12 weeks and 0.73 ± 0.30 at 12 months. By 12 weeks after treatment, the mean target leg Venous Clinical Severity Score had significantly decreased by 5.8 points, and by 12 months it had decreased by 10.0 points. CONCLUSIONS: Treatment with 1% polidocanol microfoam was associated with promising wound healing rates and low recurrence rates for VLUs, despite a challenging patient population with recalcitrant ulcers, a large percentage of which were circumferential, in patients with high body mass indexes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

UlcerVaricose UlcerHumansFemaleMiddle AgedAgedInfantMalePolidocanolSclerotherapyTreatment OutcomeWound HealingPainPolyethylene Glycols

Stichwörter der Autor:innen

Chemical ablationPolidocanolSclerotherapyVenous leg ulcerVenous reflux

Substanzen

Polidocanoldodecylnonaoxyethylene glycol monoetherPolyethylene Glycols

Autor:innen und Institutionen

  • Swedish Hospital, Northshore University HealthSystem, Chicago, IL. Electronic address: MShao@northshore.org.
  • University of Texas Health Sciences Center at Houston, Houston, TX.
  • Vascular Health Bronte, Oakville, Ontario, Canada.
  • Totality, Oklahoma City, OK.
  • Stanford University School of Medicine, Palo Alto, CA.
  • Massachusetts General Hospital, Boston, MA.

Förderung

  • Boston Scientific Corporation

Zitieren

APA

Shao, M. Y., Harlin, S., Chan, B., Santangelo, K., Fukaya, E., Stoughton, J., Kolluri, R., & VIEW-VLU Investigators (2023). VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders. https://doi.org/10.1016/j.jvsv.2023.01.011

Vancouver

Shao MY, Harlin S, Chan B, Santangelo K, Fukaya E, Stoughton J, et al. VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2023. doi:10.1016/j.jvsv.2023.01.011

BibTeX
@article{Shao2023,
  author = {Shao, Michael Y and Harlin, Stuart and Chan, Beverly and Santangelo, KathyLee and Fukaya, Eri and Stoughton, Julianne and Kolluri, Raghu and VIEW-VLU Investigators, VIEW-VLU Investigators},
  title = {VIEW-VLU observational study of the effect of Varithena on wound healing in the treatment of venous leg ulcers},
  journal = {Journal of Vascular Surgery: Venous and Lymphatic Disorders},
  year = {2023},
  doi = {10.1016/j.jvsv.2023.01.011}
}
Kostenlos starten →